Table 1.
Patient characteristics.
| MDS patients | |
|---|---|
| n = 35 (%) | |
| Age Median (IQR) | 71 (26–90) |
| Sex (M:F) | 0.7:1 |
| FAB classification | |
| – RA | 25 (71.4%) |
| – RARS | 1 (2.9%) |
| – RAEB | 5 (14.3%) |
| – CMML | 4 (11.4%) |
| WHO classification (2008) | |
| – RCUD | 5 (15.6%) |
| – RCMD | 21 (59.4%) |
| – RARS | 1 (3.1%) |
| – RAEB1 | 1 (3.1%) |
| – RABE2 | 5 (15.6%) |
| – 5q- | 1 (3.1%) |
| IPSS | |
| – Low risk | 18 (50.0%) |
| – Intermediate 1 | 12 (34.4%) |
| – Intermediate 2 | 5 (15.6%) |
| – High risk | 0 |
Data shown are absolute frequency and percentage.
IQR: interquartile range; RA: refractory anemia; RARS: refractory anemia with ring sideroblasts; RAEB: refractory anemia with excess blast; CMML: chronic myelomonocytic leukemia; RCUD: refractory cytopenia with unilineage dysplasia; RCMD: refractory cytopenia with multilineage dysplasia.